Pulished Date August, 2019
ID: 236
Share on
Share on

Asia Pacific Acute Ischemic Stroke Diagnosis & Treatment Market Analysis - By Diagnostic Type, Surgery Type, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: August, 2019
ID: 236
Pages: 136

APAC Acute Ischemic Stroke Treatment & Diagnosis Market Size & Growth (2019 - 2024)

The size of the Acute Ischemic Stroke Treatment & Diagnosis Market in the Asia Pacific is estimated to value USD 580.11 million by 2024 from USD 396.65 million in 2019, projecting a CAGR of 7.9% from 2019 to 2024.

Acute Ischemic stroke can be defined as loss of function in certain parts of the brain due to a lack of blood supply to the brain.

The Asia Pacific is the most promising market for Acute Ischemic Stroke Diagnosis and treatment owing to rising prevalence of acute ischemic stroke cases, technological advancements in surgical procedures along with rising aging population, increasing demand for minimally invasive procedures and growth in healthcare spending. High population base and growing incidence of cardiovascular are also major factors driving the market growth whereas excessive use of medication for the treatment of ischemic stroke and a high cost of surgical procedures are some of the factors restraining the market growth.

This research report segmented and sub-segmented into the following categories:

  • By Diagnostic Type: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral Angiography, And Nuclear Imaging
  • By Surgery Type: Carotid Endarterectomy, Angioplasty, And Endovascular Mechanical Thrombectomy
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

On the basis of surgery type, Carotid Endarterectomy is the largest segment accounting for a share of approximately XX% due to its high success rate, short treatment duration, and easy availability.

On the basis of region, Asia-Pacific is the most promising market for acute ischemic stroke diagnosis owing to the increasing number of patients with cardiac-related problems such as ischemic stroke. Manufacturers across various geographies are expanding their operations in the Asia-Pacific region as these regions hold immense potential for the market growth.

Major players playing a crucial role in the APAC Acute Ischemic Stroke Treatment & Diagnosis Market  profiled in this report are Abbott Laboratories, Covidien plc, Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Stryker Corporation (Concentric Medical, Inc.) and Hitachi, Ltd.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Diagnostic Type                                                        

                                5.1.1 Computed Tomography                                    

                                5.1.2 Magnetic Resonance Imaging                                         

                                5.1.3 Ultrasound                                              

                                5.1.4 Cerebral angiography                                         

                                5.1.5 Nuclear Imaging                                    

                5.2 Surgery Type                                                             

                                5.2.1 Carotid Endarterectomy                                    

                                5.2.2 Angioplasty                                             

                                5.2.3 Endovascular Mechanical Thrombectomy                                 

6. Geographical Analysis                                                                              

                6.3 Asia-Pacific                                                 

                                6.1 Introduction                                               

                                6.2 China                                             

                                6.3 India                                              

                                6.4 Japan                                            

                                6.5 South Korea                                               

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Abbott Laboratories                                                               

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Covidien plc                                                

                8.3 Johnson & Johnson                                                 

                8.4 Penumbra, Inc.                                                         

                8.5 Philips Healthcare                                                    

                8.6 GE Healthcare                                                           

                8.7 Hitachi, Ltd.                                                

                8.8 Siemens Healthcare                                                

                8.9 Stryker Corporation                                                

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • to provide both individuals and organizations a strong financial foothold in the marketInvestment opportunitiesExpertly devised analyst overview along with
  •  
  1. Asia-Pacific Acute Ischemic Stroke Diagnosis Market By Region, From 2019-2024 (USD Million)
  2. Asia-Pacific Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2019-2024 (USD Million)
  3. Asia-Pacific Computed Tomography Market By Region, From 2019-2024 (USD Million)
  4. Asia-Pacific Magnetic Resonance Imaging Market By Region, From 2019-2024 (USD Million)
  5. Asia-Pacific Ultrasound Market By Region, From 2019-2024 (USD Million)
  6. Asia-Pacific Cerebral angiography Market By Region, From 2019-2024 (USD Million)
  7. Asia-Pacific Nuclear Imaging Market By Region, From 2019-2024 (USD Million)
  8. Asia-Pacific Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2019-2024 (USD Million)
  9. Asia-Pacific Carotid Endarterectomy Market By Region, From 2019-2024 (USD Million)
  10. Asia-Pacific Angioplasty Market By Region, From 2019-2024 (USD Million)
  11. Asia-Pacific Endovascular Mechanical Thrombectomy Market By Region, From 2019-2024 (USD Million)
  12. China Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2019-2024 (USD Million)
  13. China Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2019-2024 (USD Million)
  14. India Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2019-2024 (USD Million)
  15. India Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2019-2024 (USD Million)
  16. Japan Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2019-2024 (USD Million)
  17. Japan Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2019-2024 (USD Million)
  18. South Korea Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2019-2024 (USD Million)
  19. South Korea Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2019-2024 (USD Million)
  20. Australia Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2019-2024 (USD Million)
  21. Australia Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2019-2024 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample